S100A4 and myeloid sarcoma: Therefore, to determine whether EndoMT features are present in the brain vasculature of human MS patients, we first assessed the expression levels and cellular localization of SNAI1 and FSP1, as markers of EndoMT, in well-characterized WM MS lesions and healthy controls (Table 1).